Compare SGRY & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGRY | INSP |
|---|---|---|
| Founded | 2004 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2015 | 2018 |
| Metric | SGRY | INSP |
|---|---|---|
| Price | $14.48 | $48.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 16 |
| Target Price | $22.25 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 1.0M | 973.3K |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 54.14 | ★ 179.43 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,145,438,000.00 | $82,050,000.00 |
| Revenue This Year | $5.09 | $8.02 |
| Revenue Next Year | $5.67 | $8.11 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $11.41 | $44.41 |
| 52 Week High | $24.10 | $158.24 |
| Indicator | SGRY | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 61.09 | 34.76 |
| Support Level | $13.14 | N/A |
| Resistance Level | $16.15 | $60.15 |
| Average True Range (ATR) | 0.56 | 2.85 |
| MACD | 0.02 | -0.25 |
| Stochastic Oscillator | 63.80 | 24.89 |
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.